Latest Market Access News

The a2 Milk Company has clinched final Chinese regulatory approval to rebrand infant formula products under its flagship a2™ label, completing a pivotal acquisition step. The company plans to launch these products later in 2026 and is poised to declare a $300 million special dividend.

Ragusa Minerals has completed its acquisition of a controlling interest in Pegasus Tel, gaining access to the Purple Pansy manganese-gold project in Arizona, positioning itself within a critical US supply chain sector.

Jindalee Lithium Limited’s JLLOB securities have been suspended from trading under ASX rules, reflecting unresolved compliance issues. The suspension affects only this security class, leaving other company shares unaffected.

GCM Corporation expands its VHD heat sink portfolio to 44 products and moves into liquid cooling OEM markets for AI servers, securing global distribution via DigiKey.

icetana AI has expanded its strategic partnership with SoftBank Robotics Group by signing a distribution agreement with SoftBank Robotics America, marking its entry into one of the world's largest security technology markets.

CleanSpace Holdings has achieved a major regulatory milestone with European EN 12941 certification for its new AGILE loose-fitting PAPR, positioning the company for growth in its largest market and preparing for imminent Australian approval.

LTR Pharma has locked in Strive Specialties as its exclusive US pharmacy fulfilment partner for ROXUS, marking a critical step towards commercial launch in the US erectile dysfunction market.

Develop Global has greenlit major investments in its Sulphur Springs copper-zinc and Pioneer Dome lithium projects, backed by a US$400 million financing and offtake deal with Trafigura that also refinances Woodlawn.

Core Lithium has secured a second sale of 25,000 tonnes of lithium fines from its Finniss stockpile to Glencore, adding to A$28.5 million in revenue for 2026 and supporting ongoing development at Finniss.

Imugene’s off-the-shelf CAR T therapy azer-cel has won FDA Fast Track Designation for relapsed or refractory CLL/SLL and MZL, backed by compelling Phase 1b response rates.

First Graphene accelerates its US expansion by acquiring MITO Material Solutions, gaining functionalised graphene technologies and a direct commercial foothold in the world’s largest defence and aerospace market.

Control Bionics advances its neural-signal technology across assistive communication, sports, and medical sectors, securing key US reimbursement and distribution agreements while broadening its international footprint.